Apogee Therapeutics Inc (APGE)

Cash & Short-Term Investments

$971.93M

Quarterly · Period ending: · USD

APGE logo

APGE Cash & Short-Term Investments

Latest reported$971.93M
APGE Quarterly Cash & Short-Term Investments ($151.89M → $971.93M)
High-resolution chart · PNG

APGE cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Apogee Therapeutics Inc Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
971,926,000
1,059,885,000
730,192,000
527,289,000
505,420,000
513,329,000
520,653,000
526,049,000
676,228,000
816,196,000
395,459,000
422,854,000
125,069,000
141,333,000
151,890,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.